Common Stock, $0.001 par value per share
- Symbol
- HTFL
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
Heartflow, Inc.
HTFLNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition . On March 18, 2026, Heartflow, Inc. issued a press release regarding its financial results for the quarter and full year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Company context
Heartflow’s technology is redefining precision diagnostic testing and management for coronary artery disease (CAD) through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 800,000 patients worldwide. 1 Key benefits include:
Current securities
Registered securities in this filing
Heartflow, Inc. · 8-K · Filed 2026-03-18
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02
Results of Operations and Financial Condition
.
On March 18, 2026, Heartflow, Inc. issued a press release regarding its financial results for the quarter and full year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Filed exhibits (1)
EX-99.1 2 htfl-20260318xex99_1.htm EX-99.1 Exhibit 99.1 2026.03.18 Exhibit 99.1 Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results MOUNTAIN VIEW, Calif. - March 18, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights Total revenue of $49.1 million, a 40% increase year-over-year Gross margin of 79.5%, non-GAAP gross margin of 79.9% Net operating loss of $17.8 million, non-GAAP net operating loss of $12.5 million U.S. installed base of 1,465 accounts as of December 31, 2025 U.S. Plaque installed base of 489 accounts as of December 31, 2025 ────────────────────────────────────────────────────────────────────── Aetna began coverage of Heartflow Plaque Analysis, bringing total U.S. covered lives for Plaque to approximately 75% 2026 Annual Guidance Total revenue of $218 million to $222 million (approximately 24% to 26% growth year-over-year) Non-GAAP gross margin of 80% to 81% “Our strong fourth quarter performance concluded a record year…
Open exhibit ↗